Sequella's Grant - V Round

Sequella raised a round of funding on June 14, 2000. Investors include Small Business Innovation Research Awards.

Sequella is a clinical stage antiinfectives company focused on discovering, developing, and commercializing improved treatments for serious infectious diseases. The company leverages its global influe…

Articles about Sequella's Grant - V Round: